Non-coding RNAs in disease: from mechanisms to therapeutics

被引:248
|
作者
Nemeth, Kinga [1 ]
Bayraktar, Recep [1 ]
Ferracin, Manuela [2 ,3 ]
Calin, George A. [1 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Translat Mol Pathol Dept, Houston, TX 77030 USA
[2] Univ Bologna, Dept Med & Surg Sci DIMEC, Bologna, Italy
[3] IRCCS Azienda Osped Univ Bologna, Bologna, Italy
[4] Univ Texas MD Anderson Canc Ctr, RNA Interference & Noncoding RNA Ctr, Houston, TX 77030 USA
关键词
CORONARY-ARTERY-DISEASE; CIRCULAR RNAS; PROGNOSTIC BIOMARKER; TRANSCRIPTION FACTOR; PROFILING REVEALS; PERIPHERAL-BLOOD; DOWN-REGULATION; POOR-PROGNOSIS; HEART-FAILURE; CELL-CYCLE;
D O I
10.1038/s41576-023-00662-1
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Non-coding RNAs (ncRNAs) are a heterogeneous group of transcripts that, by definition, are not translated into proteins. Since their discovery, ncRNAs have emerged as important regulators of multiple biological functions across a range of cell types and tissues, and their dysregulation has been implicated in disease. Notably, much research has focused on the link between microRNAs (miRNAs) and human cancers, although other ncRNAs, such as long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs), are also emerging as relevant contributors to human disease. In this Review, we summarize our current understanding of the roles of miRNAs, lncRNAs and circRNAs in cancer and other major human diseases, notably cardiovascular, neurological and infectious diseases. Further, we discuss the potential use of ncRNAs as biomarkers of disease and as therapeutic targets. In this Review, the authors describe our current knowledge of the role of microRNAs, long non-coding RNAs and circular RNAs in disease, with a focus on cardiovascular, neurological, infectious diseases and cancer. Further, they discuss the potential use of non-coding RNAs as disease biomarkers and as therapeutic targets.
引用
收藏
页码:211 / 232
页数:22
相关论文
共 50 条
  • [21] Dysregulation of long non-coding RNAs and their mechanisms in Huntington's disease
    Tan, Xiaoping
    Liu, Yang
    Liu, Yan
    Zhang, Taiming
    Cong, Shuyan
    JOURNAL OF NEUROSCIENCE RESEARCH, 2021, 99 (09) : 2074 - 2090
  • [22] Non-coding RNAs in Kawasaki disease: Molecular mechanisms and clinical implications
    Yang, Fuqing
    Ao, Xiang
    Ding, Lin
    Ye, Lin
    Zhang, Xuejuan
    Yang, Lanting
    Zhao, Zhonghao
    Wang, Jianxun
    BIOESSAYS, 2022, 44 (06)
  • [23] Transcription regulation by long non-coding RNAs: mechanisms and disease relevance
    Jorge Ferrer
    Nadya Dimitrova
    Nature Reviews Molecular Cell Biology, 2024, 25 : 396 - 415
  • [24] Eukaryotic non-coding RNAs: new targets for diagnostics and therapeutics?
    Rossbach, O.
    Bindereif, A.
    PHARMAZIE, 2016, 71 (01): : 3 - 7
  • [25] Bladder cancer: non-coding RNAs and exosomal non-coding RNAs
    Zhao, Jingang
    Ma, Yangyang
    Zheng, Xiaodong
    Sun, Zhen
    Lin, Hongxiang
    Du, Chuanjun
    Cao, Jing
    FUNCTIONAL & INTEGRATIVE GENOMICS, 2024, 24 (05)
  • [26] Non-coding RNAs and exosomal non-coding RNAs in pituitary adenoma
    Rahimian, Neda
    Sheida, Amirhossein
    Rajabi, Mohammadreza
    Heidari, Mohammad Mahdi
    Tobeiha, Mohammad
    Esfahani, Pegah Veradi
    Asouri, Sahar Ahmadi
    Hamblin, Michael R.
    Mohamadzadeh, Omid
    Motamedzadeh, Alireza
    Mahabady, Mahmood Khaksary
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 248
  • [27] Coding in non-coding RNAs
    Waterhouse, Peter M.
    Hellens, Roger P.
    NATURE, 2015, 520 (7545) : 41 - 42
  • [28] Coding in non-coding RNAs
    Peter M. Waterhouse
    Roger P. Hellens
    Nature, 2015, 520 : 41 - 42
  • [29] Comprehensive review for non-coding RNAs: From mechanisms to therapeutic applications
    Zhang, YanJun
    Zhan, Lijuan
    Jiang, Xue
    Tang, Xiaozhu
    BIOCHEMICAL PHARMACOLOGY, 2024, 224
  • [30] Mechanisms of tamoxifen resistance: insight from long non-coding RNAs
    Yan, Yuxin
    Zhang, Jian
    FRONTIERS IN ONCOLOGY, 2024, 14